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OPEN

The Art and Science of Infusion Nursing

Implementation of Smart Pump Technology
With Home Infusion Providers
An Assessment of Clinician Workflow and Patient Satisfaction
Thomas D. Brown, PharmD, MBA  Martha Michael, BSN, RN, CRNI® 
David S. Grady, PharmD, MBA

ABSTRACT
While hospitals have adopted smart pump technology (SPT) featuring drug libraries and medication safety software,
most home infusion providers (HIPs) continue to use traditional infusion pumps that don’t offer drug libraries or
medication safety software. As infusion delivery is moving from the hospital to the home, the purpose of this study
was to determine whether SPT was a feasible alternative at both a hospital-based and a rural HIP. HIP personnel were
trained on an ambulatory infusion pump. Patients requiring home infusion used the pump and recorded daily pump
interactions for 5 to 7 days. After the creation of a drug library, clinicians felt comfortable programming pumps after
7 uses. Patients reported 100% overall satisfaction, and the majority of alarms were resolved without contacting the
HIP. Ambulatory SPT can be implemented successfully by HIPs and can be used effectively by patients.
Key words: ambulatory infusion, CADD, drug library, home infusion, medication safety software, smart pump

T

he ability of patients to receive intravenous infusions
in a home setting has been an option for patients in
the United States since the 1980s. The use of home
infusion will continue to expand in response to the
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needs of an aging population, further adoption of outpatient
surgical procedures, and the push to reduce health care
costs. This shift is being accelerated as a result of compressed
reimbursement and incentives to reduce hospital length of
stay. Infusions in alternative sites are estimated to represent
approximately $9 billion to $11 billion each year in US health
care expenditures.1 Although much of the current home
infusion literature focuses on postoperative pain management, the backbone of the home infusion business remains
hydration, antibiotic delivery, and parenteral nutrition (PN),
with treatments also including inotropes, chemotherapy,
and immunoglobulin therapy.2-7 Infusion delivery has moved
from the hospital to the home not only in the United States
but also across the world, demonstrating cost savings and
improving patients’ quality of life.8,9
Although hospitals have adopted pumps with drug
libraries and medication safety software, ie, smart pumps,
most home infusion providers (HIPs) continue to use traditional infusion pumps that don’t have drug libraries or medication safety software. Smart pumps are used ideally when
an accurate and controlled rate of infusion is required,
such as with chemotherapy (eg, fluorouracil [5-FU] or
PN). However, questions remain about the amount of
work and value smart pump technology (SPT) brings to
HIPs and whether patients will be able to use the devices
independently. A device with the potential to increase the
safety of infusions, while at the same time decreasing home
care visits or calls, would improve the efficiency of the HIP’s
Journal of Infusion Nursing

operations significantly, but only if patients accepted the
device.
The purpose of this study was to determine whether SPT
is a feasible alternative (versus manual pump programming)
to previously used, traditional “dumb” ambulatory infusion
pump technology, in both large, urban hospital-based HIPs
and in small rural HIPs, by evaluating the implementation
and satisfaction of clinicians in the HIP, as well as patient
feedback on pump use and performance in the home.

METHODS
Study Design
This study was a prospective, dual-center, single-arm,
postmarket study conducted in the United States in accordance with the ethical standards of the governing institutional review board (IRB) (ClinicalTrials.gov identifier
NCT01997099). There were 2 independent phases of the
study, conducted consecutively at each HIP. Following IRB
approval of both phases, HIP clinicians were trained on a
new ambulatory smart pump and medication safety software (CADD-Solis VIP; Smiths Medical, Minneapolis, MN).
Phase 1 consisted of data collection to describe the process that was used to introduce SPT to home health care
organizations. Phase 2 included pump interaction and satisfaction data collection from patients who received home
infusion therapy with a smart pump.
For phase 1, clinicians documented details of their training, drug library creation, pump data entry, and validation
efforts. Each staff member performed 10 scenarios simulating pump programming, using the completed library, and
assessed pump programming efforts.
The urban HIP trained patients how to use the pump,
and clinicians subsequently answered questions about the
implementation and patient training process. Both HIPs
then assessed their overall workflow changes and evaluated the new system.
The objectives of phase 1 were to characterize the effort
required to create a new protocol library and the ease of
use associated with programming the pump; summarize
and describe any possible programming errors; assess the
home health nurses’ perceptions of patient training and
device setup in the home; and evaluate the needed organizational workflow changes when adopting the new system.
In phase 2, patients were enrolled if they required home
infusion for at least 5 days and had no previous experience
with the study device. Patients had to be 18 years of age
or older. The study was conducted between February 2014
and June 2014 for the first site and January 2015 to October
2015 for the second. Patients’ personal caregivers (PCGs)
who were primarily responsible for device interaction
were allowed to enroll patients and agreed to comply with
the data collection requirements. Patients or their PCGs,
referred to hereafter as patients, recorded pump interaction details for 5 to 7 consecutive days after the infusion
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began. Patients were allowed to provide free-text feedback,
and they completed a questionnaire on their interaction.
The patients were called 24 to 96 hours after the infusion began to confirm pump diary completion and again at
7 to 10 days to answer questions about overall satisfaction
with the pump and to confirm the return of the pump diary.
The primary objective of phase 2 was to assess the overall
satisfaction of patients, as rated on a 6-point Likert scale, at
the end of the study follow-up visit. Patients’ experiences
were prospectively considered a success if the overall satisfaction with the pump was rated as somewhat agree or better and is represented as a proportion of successful patient
experiences to all patients enrolled. Secondary objectives of
this phase were to summarize the number of alarms reported, quantify the ability of the patients to troubleshoot the
alarms successfully without contacting the home health care
provider, summarize any difficulties experienced with use of
the device, and characterize the ease of use of the pump’s
various features, as reported on a 6-point Likert scale.

Statistical Analyses
Formal hypothesis testing was not planned or completed
for this study. Descriptive statistics were used to summarize
data from all clinicians and patients for each phase of the
study. Because of the different HIP sizes and the types of
patients they served, phase 1 data were evaluated individually for each HIP. For quantitative variables, N (total sample
size), mean, median, standard deviation, minimum, maximum, and range were reported. For qualitative variables,
frequency and percentage were reported.

RESULTS
Phase 1
The clinicians who participated in the study and evaluated
the system implementation had varying experience in the
home infusion profession and were either pharmacists or
nurses.

Library creation: large, urban hospital-based
HIP
Three clinical pharmacists championed an infusion implementation team, and each spent 9 hours completing online
training modules and in-person software and pump training
sessions by the device manufacturer. The team began the
library creation process by choosing general pump settings
after physically testing and observing the actual pump.
Protocol template settings were then selected based on
the HIP’s preferences, being mindful of the specific population served and the therapies typically provided. Example
protocols were created to help determine the best way to
describe and develop the qualifier and drug name descriptions in the drug library.
To begin the actual library creation process, continuous and
intermittent therapies were created first, since concentrations
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and the compounding of these medications typically do not
change, and it was easiest to transition the familiar standards
into the library. PN was approached next, with the protocol
qualifier based on a volume range, drug name, and infusion
duration.
The team then created step therapy, which was designed
based on branded dosing recommendations and rate increment increases. The qualifiers were chosen as weight
(10-kg weight range), and the drug name was the branded
product and concentration. Patient-controlled analgesia
(PCA) protocols were the last created, and the team used
broad programming (eg, hydromorphone 2 mg/mL with a
hard upper limit of 200 mg/h) because hospice patients
were primarily served. This approach allowed a balance
between the need to titrate doses versus the need to have
hard maximums.
The team created 266 protocols for the drug library over
the course of 6 business days, spending a total of 27 hours
on the process (Table 1). The team had a pharmacy resident
spend 17.5 hours entering the protocols into the safety software and another 7.5 hours performing validation activities
to ensure the accuracy and completeness of the protocols.

Library creation: small rural HIP
Two nurses and 1 pharmacist participated in the library
creation process for site 2, reporting an average training
time of 7.8 hours each, which included online modules and
in-person training by the manufacturer. The team created a
total of 12 protocols for its library in a total of 8 man-hours
over 2 business days (Table 1). The first step for the team
was to document a brief overview of the facility’s current
workflow, after which it was determined that a template
library for each therapy type would be created, but without
defining the drug, qualifier, or specific safety limits. After
the 5 templates were completed, individual protocols were
created and references consulted.
TABLE 1

Drug Library Creation Efforts
Criteria

Large, Urban
Hospital-based HIP

Small Rural
HIP

Participants

3 clinical pharmacists

2 nurses
1 pharmacist

System training time
(mean)

9 h per person

7.8 h per
person

Number of protocols
created

266

12

Protocol creation time

27.0 h

3.5 h

MSS entry time

17.5 h

3.5 h

Validation time

7.5 h

1.0 h

Business days spent
working on library

14

2

Abbreviations: h, hour(s); HIP, home infusion provider; MSS, medication safety
software.

346

Copyright © 2018 The Authors. Published by Wolters Kluwer Health, Inc.
on behalf of the Infusion Nurses Society.

Continuous infusions are the most common infusions at
the site and were created first. For continuous infusions,
the following qualifiers were used: 44h, 5-FU; 46h, 5-FU;
48h, 5-FU; hydration, 0.9% sodium chloride; nafcillin; Ancef
(cefazolin). The next delivery mode selected was PCA. The
2 qualifiers were PCA naive and tolerant. These infusions
were rarely administered, so the site used previously used
rates and concentrations.
Intermittent and step therapies on electronic ambulatory
pumps were not common at the site and were approached
next. Previously used infusion rates and concentrations
were used for the protocols. Finally, taper delivery mode for
PN was examined. The HIP used a few sets of safe parameters in the template to be able to check volume and dose.
A wide range was given to accommodate various infusion
rates, and orders and all qualifiers were labeled PN 12 hour.

Pump programming and implementation
evaluation
Once the library had been completed at both HIPs, clinicians (N = 13) completed a total of 130 pump programming
scenarios, using historical patient orders from the HIPs.
Seven programming errors (5.4%) were reported during
the validation review (during the second pharmacy review):
3 related to the programming of the reservoir volume; 1
had an incorrect PCA lockout time; 1 had the maximum
doses per hour for a PCA order; 1 had an incorrect infusion
duration; and 1 did not use the drug library that was downloaded on the pump, because the pump was programmed
manually. Clinicians rated the ability to view the pump status and view and adjust parameters on 1 screen as the most
beneficial features of the pump. They reported with 99.2%
(129/130) agreement that the pump was easy to program,
and on average, they were comfortable with programming
the device after an average of 6.85 uses.
Five clinicians at site 1, the large urban hospital-based
HIP, subsequently performed a total of 28 implementations
for the HIP’s teaching evaluations on patients requiring infusions with continuous (n = 1), intermittent (n = 13), and
taper (n = 14) therapy types. The mean training time per
patient was approximately 40 minutes, with patients having
an excellent (n = 13), good (n = 14), or fair (n = 1) understanding of the pump at the end of the sessions. Priming the
pump was reported as the easiest feature to train on, and
the most difficult was reported as resetting the reservoir
volume. Pump features that clinicians consistently rated
highest were the ability to view the pump status and the
size of the pump screen. Clinicians reported that they were
comfortable and confident training with the new pump after
an average of 2 implementations.

Phase 2
A total of 42 patients were enrolled in the study across
both sites, with a broad representation of ages, genders,
and levels of experience with ambulatory infusion pumps
(Table 2). All patients reported no hearing impairment;
Journal of Infusion Nursing

TABLE 2

Patient Demographics
N = 42

Characteristics

Age (years)
Mean (SD)

58.4 (13.3)

Median (min, max)

59 (24, 77)

Gender
Female

21/42 (50.0%)

Male

21/42 (50.0%)

Experience using an ambulatory infusion pump?
Yes

14/42 (33.3%)

No

28/42 (66.7%)

Patient’s/caregiver’s level of understanding of the training
instructions
Excellent

20/41 (48.8%)

Good

16/41 (39.0%)

Fair

5/41 (12.2%)

Therapy
Taper

24/42 (57.1%)

Intermittent

12/42 (28.6%)

Continuous

6/42 (14.3%)

of assessing overall patient satisfaction. All experiences
were successful, with each patient (100%) reporting overall
satisfaction with the pump as somewhat satisfied or better
(Figure 1).
Pump diaries were returned from 39 patients reporting
experiences from 265 total pump use days. A total of 152
alarms were reported on 106 pump days from 28 of the 39
patients (71.8%). Alarms were not predefined, and patients
reported the presence of alarms differently. Some considered any notification from the pump as an alarm (eg, infusion complete), while others only reported alarms that had
an impact on therapy delivery. A breakdown of the alarm
types and frequencies is presented in Table 3. Infusion complete notifications comprised 34.2% (52/152) of the total
alarms reported. Of the 51 high-priority alarms reported, 39
were the result of occlusion with 17 downstream (43.6%), 12
upstream (30.8%), and 7 not specified (17.9%). One patient
reported experiencing 10 downstream occlusion alarms in
the same day. All 3 system fault alarms were resolved by the
patients after removing and restoring the same batteries.
Patients reported on a daily basis, not per alarm, if
they contacted the HIP for pump troubleshooting. Of the
106 days when alarms were reported, patients were able

Disposable used
Administration set

31/42 (73.8%)

Cassette

11/42 (26.2%)

Air-in-line sensitivity
High

0/0 (0.0%)

Low

28/42 (66.7%)

Off

14/33 (33.3%)

Abbreviations: max, maximum; min, minimum; N, total participants; SD, standard
deviation.

42.9% (18/42) required glasses for vision impairment, and
7.1% (3/42) reported decreased finger dexterity that could
have an effect on pump interactions. An infusion nurse provided the patient or caregiver with pump training, including
training with the pump’s help screens and pump operation.
All infusions were delivered intravenously (88.1% [37/42]
by means of a peripherally inserted central catheter;
11.9% [5/42] via an implanted port). The types of infusions
delivered were taper, intermittent, or continuous, using
either an administration set (73.8%) or cassette (26.2%)
and an air-in-line sensitivity feature set to either low or off
(Table 2). Drugs administered for the taper therapy were
all PN infusions. Intermittent therapies were primarily penicillin, Unasyn, nafcillin, or piperacillin/tazobactam, and the
continuous infusions were milrinone (n = 1), Ancef (n=5),
and 5-FU (n = 1).
Forty of the 42 patients (95.2%) completed the end-ofstudy visit form and contributed to the primary objective
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Figure 1 Forty of the 42 pa ents enrolled in the study (95.2%)
completed the end-of-study visit form and contributed to the primary
objec ve of assessing overall pa ent sa sfac on. The 40 completed
end-of-study visit forms indicated that experiences were successful,
with each respondent pa ent repor ng overall sa sfac on with the
pump as somewhat sa sfied or be er.
Copyright © 2018 The Authors. Published by Wolters Kluwer Health, Inc.
on behalf of the Infusion Nurses Society.
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TABLE 3

TABLE 4

Alarms Experienced by Patients

Patient-Reported Device
Difficulties

Alarm Type

Alarms Reported
N = 152

Low priority
Pump not started
Infusion completed
Low battery

Measure

2
52
6

Medium priority
Low reservoir

28

Pump unable to be started without
latched and locked cassette

13

N = 265 Pump Use Days
(% Infusion Days)

Daily device or component
difficulties reported

23/265 (8.7%)

Patients with device or component
difficulties

14/39 (35.9%)

Area of difficulty

High priority

n = 23 areas of diﬃcultya

Stopping alarm(s)

8/25 (32%)

Starting or restarting pump

5/25 (20%)

Changing bag, tubing, cassette

3/25 (12%)

Stopping the pump

2/25 (8%)

Occlusion

39

Air in line

9

Resetting infusion volume

2/25 (8%)

System fault

3

Priming tubing

2/25 (8%)

Changing or charging batteries

2/25 (8%)

Volume of infusion “complete”
tone too soft

1/25 (4%)

to resolve the alarms successfully without contacting the
HIP 86.8% of the time (92 days). Of the 14 days when the
HIP was contacted about an alarm, a total of 17 alarms
were reported: air in line (5), occlusion (4), other (2), low
reservoir (1), starting pump (1), infusion complete (2), system error (1), and high pressure (1). Of the 92 days with
alarms that did not require the patient to contact the HIP,
patients were asked to rate the ease of resolving the alarm
independently and indicate whether they used the help
screens to resolve the issue. Of the questions answered,
79/81 (97.5%) rated the ease of resolving the alarm as easy,
and 38/82 (46.3%) used the pump help screens.
Table 4 describes patient-reported device difficulties.
Fourteen of the 39 (35.9%) patients reported experiencing
device difficulties on 23 days (8.7%). Of the areas of difficulty reported, stopping alarm(s) and starting or restarting the
pump were most common. Despite reporting difficulties
with the pump on 23 days, the patients still reported satisfaction with the device on 99.6% of all the device-use days.
Patients were also asked to rate 14 overall “ease-ofuse” statements related to their handling of the pump and
reported 100% agreement with 10 statements and 94.3%
to 97.5% with 4 statements. All but 1 patient (97.5%)
agreed they would recommend the pump to others who
needed home infusion therapy.

DISCUSSION
Medication errors can be a serious issue, and hospitals have
been working on protocols to reduce their occurence.10
SPT features drug libraries and medication safety software
that have been developed to reduce medication errors.11
While hospitals have adopted SPT, most HIPs are still using
traditional infusion pumps that do not use drug libraries or
medication safety software. This study indicates that SPT
348
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Daily satisfaction with pump

n = 258 responses

Very satisfied

209/258 (81%)

Satisfied

42/258 (16.3%)

Somewhat satisfied

6/258 (2.3%)

Dissatisfied

1/258 (0.4%)

a

Patients may have reported more than 1 area of difficulty per day.

could be applicable in large urban and in rural HIPs. SPT in
HIPs positively had an impact on pump programming, clinician workflow, and ease of use for patients in their homes.
The first step in the implementation of smart pumps
was the creation of drug libraries. During this step, several improvement opportunities were identified, including
tremendous variation in prescription labels for the same
therapies and a lack of standardized concentrations. These
were seen with both taper therapies and step therapies.
With taper therapies, there was concern about ensuring
that correct volume and duration were programmed. With
step therapy, it was cumbersome to address specific disease-state dosing when there were different dosing parameters for different diagnoses, eg, chronic inflammatory
demyelinating polyneuropathy versus primary immunodeficiency for Gamunex. In these cases, the more conservative
dosing regimen prevailed. Package inserts were also used
to determine protocol parameters, such as initial, maintenance, and maximum infusion rates. A standardization
project was initiated to address the deficiencies noted,
resulting in the creation of standard labels and the adoption of standardized concentrations.
The smart pump software encouraged the standardization of drug concentrations and prescription labels,
and streamlined the pump distribution process. These
Journal of Infusion Nursing

measures suggest a decreased risk of pump programming
errors by eliminating the need to program manually or to
copy from previous patients. Additional studies are needed
to demonstrate an impact of these measures on drug programming error rates. Building a library is an investment
of time and resources that can save time and increase
safety in the long term. The financial effects of standardization were outside the scope of this study but should be
considered for potential cost savings and improved risk
management.
The user interface of the pump was robust and had a
positive impact on the clinician’s ease of use. The increased
ease of use may have a direct impact on the ease in patient
teaching, as reflected by 100% of clinicians reporting that
it is easier to teach how to use a smart pump than other
infusion pumps. The use of drug libraries minimizes the
need for clinicians to learn extensive pump programming.
This allows for increased focus on fewer tasks, such as confirming settings with the drug label, and leads to improved
patient safety. It is anticipated that this robust user interface will facilitate the education of external or partner
nursing agencies new to pumps.
Alarms were the most frequently cited difficulty associated with pump use. However, 96.5% of patients found it
somewhat easy to very easy to resolve alarms using help
screens, and 98% of the time, patients found it somewhat
easy to very easy to resolve alarms without help from the
provider. The ability to resolve alarms independently, without contacting the HIP for assistance, may have a workflow
and a financial impact, although this study did not look
at those factors. Increased patient ease of use, low alarm
rates, and the ability to address alarms independently
resulted in general satisfaction with the pump.

CONCLUSION
Ambulatory SPT can be implemented successfully in large
urban and small rural HIPs. Clinicians indicated that the
pump was easy to use and appreciated the drug library
creation process for improved protocol consistency with
potential improvements in patient safety. This study also
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demonstrated that SPT can be used effectively by patients
with a high level of satisfaction. Smart pumps could be a
feasible approach for HIPs of any size or at any location.
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